Detalhe da pesquisa
1.
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
Brain
; 147(3): 936-948, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787146
2.
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
Brain
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527854
3.
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.
Mol Cell Proteomics
; 22(10): 100629, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37557955
4.
Structural flexibility and heterogeneity of recombinant human glial fibrillary acidic protein (GFAP).
Proteins
; 92(5): 649-664, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149328
5.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
J Neurol Neurosurg Psychiatry
; 95(5): 392-400, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963723
6.
Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
Am J Geriatr Psychiatry
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553327
7.
Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
Clin Chem Lab Med
; 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215341
8.
Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
Brain
; 146(5): 2045-2058, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703180
9.
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
Brain
; 146(3): 1166-1174, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511164
10.
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
Brain
; 146(11): 4495-4507, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348871
11.
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis.
Ann Hepatol
; 29(3): 101496, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460714
12.
Novel avenues of tau research.
Alzheimers Dement
; 20(3): 2240-2261, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170841
13.
Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.
Alzheimers Dement
; 20(4): 2980-2989, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477469
14.
Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery.
J Proteome Res
; 22(9): 3068-3080, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606934
15.
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.
J Neuroinflammation
; 20(1): 107, 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147668
16.
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis.
J Neuroinflammation
; 20(1): 215, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752582
17.
Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy.
J Neurol Neurosurg Psychiatry
; 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879899
18.
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
Mult Scler
; 29(9): 1070-1079, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317870
19.
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
Mult Scler
; 29(10): 1229-1239, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530045
20.
Bronchopulmonary dysplasia is not related to neurofilament light for neuroaxonal damage in preterm infants.
Pediatr Res
; 93(7): 2014-2018, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344694